Intravenous N-acetylcysteine is associated with fewer of the adverse effects seen with the oral preparation, such as nausea, vomiting, abdominal pain, diarrhea and rash, but it carries a higher risk of anaphylactoid reactions.9 When patients present relatively late after ingestion, oral N-acetylcysteine protocols provide a higher dose given over a longer period, which may be an advantage.2 , 10 However, the gastrointestinal adverse effects associated with oral therapy are a substantial disadvantage, notably if this results in a longer time for drug absorption and hence a longer time to reach therapeutic effect.2 Since the introduction and adoption of routine use of N-acetylcysteine therapy, the mortality rate in acetaminophen overdose has declined from 3% to 0.7%.11 Prevention of overdose and medication errors in children This report highlights the issue of accurate dosing in pediatrics
A clinical trial has shown that acetazolamide effectively increases the mean pulmonary artery flow acceleration time while reducing the pulmonary vascular resistance index in patients with CMS (Leon-Velarde et al., 2010)
Staroverov, V
Stay consistent is what we'll recommend
Mitochondrial respiratory complex activity measurement The enzymatic activities of complex I (NADH ubiquinone reductase), complex II (succinate ubiquinone reductase), complex III (ubiquinol cytochrome C reductase), and complex IV (cytochrome C oxidase) were measured in macrophages using enzyme activity assay kits (A089-1-A089-4, Nanjing Jiancheng Bioengineering Institute, China) according to the manufacturer's instructions
, and Maecki A
